Results
|
2701.
|
|
|
2702.
|
|
|
2703.
|
|
|
2704.
|
|
|
2705.
|
|
|
2706.
|
RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials. [electronic resource] by
- Oronsky, Bryan
- Paulmurugan, Ramasamy
- Foygel, Kira
- Scicinski, Jan
- Knox, Susan J
- Peehl, Donna
- Zhao, Hongjuan
- Ning, Shoucheng
- Cabrales, Pedro
- Summers, Thomas A
- Reid, Tony R
- Fitch, William L
- Kim, Michelle M
- Trepel, Jane B
- Lee, Min-Jung
- Kesari, Santosh
- Abrouk, Nacer D
- Day, Regina M
- Oronsky, Arnold
- Ray, Carolyn M
- Carter, Corey A
Producer: 20170310
In:
Expert opinion on investigational drugs vol. 26
Availability: No items available.
|
|
2707.
|
|
|
2708.
|
|
|
2709.
|
|
|
2710.
|
|
|
2711.
|
|
|
2712.
|
|
|
2713.
|
|
|
2714.
|
|
|
2715.
|
|
|
2716.
|
|
|
2717.
|
|
|
2718.
|
|
|
2719.
|
|
|
2720.
|
|